This finding may point to a latent state of elevated platelet activation in the circulation of GBM patients rather than a predominant effect on platelet activation under maximal agonistic conditions as induced by the incubation with ADP or TRAP in-vitro. The gene discussed is CD40LG; the disease is glioblastoma.